The data is from a single patient sample, and the assay conditions have not been optimised. How does ASX allow them to announce this???
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test, page-18
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $62.03M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 56.0¢ | 55.5¢ | $15.61K | 28.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 46310 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 1116 | 1 |
View Market Depth
| Last trade - 15.42pm 04/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |